Summary.-Transformation of rat embryo fibroblasts in vitro has been investigated using initiation with either benzo(a)pyrene (BaP), 7,12-dimethylbenz(a)anthracene (DMBA) or benzo(e)pyrene (BeP) and promotion with either phorbol ester (TPA) or croton oil (Cr.Oil). The criteria used to assess in vitro transformation were (a) the efficiency of cloning in liquid medium, (b) abnormal cellular morphology and (c) the development of malignant tumours following s.c. inoculation of newborn rats.
development of malignant tumours following s.c. inoculation of newborn rats.
The results show that the cloning efficiency, which remained low in the control cells, was increased to a variable extent in the treated groups. Transformation occurred in all groups, but occurred earliest in cells that were initiated and promoted. Initiation with DMBA or BaP and promotion with TPA or Cr.Oil led to the earliest acquisition of malignancy. Correlations were found between the transformation of cells in vitro and the acquisition of malignant potential, and between the carcinogenic action of the compounds in vitro and their action in vivo, but cloning efficiency was not a reliable indicator of in vitro transformation or of malignancy. In most cases in vitro transformation appeared to precede the acquisition of malignancy, but in two cases it occurred later. The studies also show that BeP, which is a tumour initiator in vivo, also acts in this way in vitro. The conclusion drawn from a discussion of these results and of two -stage carcinogenesis in vivo is that two -stage carcinogenesis can be reproduced in tissue culture; this model may be useful in studies of those mechanisms of chemical carcinogenesis that involve the processes of initiation and promotion.
FRIEDEWALD AND Rous (1944) first defined that " carcinogenesis was composed of an initiating process, responsible for the conversion of normal into latent tumour cells, and a promoting process, whereby these latent tumour cells were made to develop into actual tumours ". The real development of 2-stage carcinogeinesis was due to Berenblum, who originally used the term " precarcinogenic actioil " for the initiation and " epicarcinogenic action" for the promotion, but in the interest of uniformity he later adopted the terms " initiation " and " promotion " (Berenblum, 1941 (Berenblum, , 1974 Shubik, 1947, 1949) .
The early experimental work on cocarcinogenesis was carried out exclusively in vivo. However, in vivo techniques are not suitable for examining the phenomena at the cellular level. Since the malignant transformation of fibroblasts can be induced in vitro by chemicals (Berwald and Sachs, 1963; Chen and Heidelberger, 1969: DiPaolo. Donovan and Nelson, 1969) (MacPherson, 1970) . Our aim has therefore been to reproduce in vitro the phenomenon of 2-stage carcinogenesis.
We have previously reported an acceleration of the transformation of rat fibroblasts in vitro after initiation with benzo(a)pyrene, followed by a promoting treatment with phorbol ester (Lasne, 1973;  Lasne, Gentil and Chouroulinkov, TWO-STAGE CARCINO GENESIS 1974 
Transformation assay
The effects of the different treatments on the cells, were estimated, at intervals, as shown in Fig. 5 . The tests consisted of cloning in liquid medium, the results being expressed by (a) the cloning efficiency (CE), and (b) the transformation efficiency (TE), and of the s.c. inoculation of the cells into newborn rats expressed by (c) the malignancy.
Cloning efficiency (CE).-Tissue culture cells, when sparsely seeded, tend to develop into colonies (Puck and Marcus, 1955) . After trypsinization, 200 cells from each group were suspended in 2 ml of Dulbecco's medium supplemented with 20% foetal calf serum and were plated in 60-mm plastic Falcon Petri dishes and incubated at 37°C in an atmosphere of air with 10% CO2. Ten days later the colonies were fixed in methanol and stained with Giemsa. The percentage of plated cells developing into colonies is indicative of the cloning efficiency (CE) of the cells.
Transformation (T).-The transformation in these experiments was recognized by the abnormal morphological characteristics of the colonies, such as a loss of cell orientation and a piling-up of the cells in a random criss-cross pattern (Berwald and Sachs, 1965 Malignancy.-The malignancy of the cells was determined by inoculation into animals. The treated and control cells from different passages were inoculated s.c. into the cranial region of 2-day-old isologous Wistar rats, each animal receiving 2 or 3 x 106 cells as a suspension in 0.05 ml of culture medium. The animals were subsequently examined twice a week for palpable tumour formation, for a period of at least 6 months. Systematic histological examination was performed on all tumours; these appeared to be fibrosarcomas.
RESULTS

Cloning efficiency
In Exp. I (Fig. 1 ) the CE of the solvent control cells remained low; the CE of the cells treated with DMBA or with DMBA + TPA increased at P32-P36, whereas that of the TPA treated cells increased rapidly at P16. In Exp. II (Fig. 2) 
Malignancy
Malignancy of the control cells (or "spontaneous malignant transformation ") was demonstrated at P55 (275 days of culture) for Exp. I (Fig. 5) , and at P67 (335 days) for Exp. II (Fig. 5) (Puck and Marcus, 1955 
Transformation and malignancy
Abnormal colony morphology is considered as a criterion of transformation, especially with studies using Syrian hamster cells (Berwald and Sachs, 1963) in which transformation can vary from 0 to 25% depending on the treatment and on the experimental conditions (Berwald and Sachs, 1965; DiPaolo et al., 1969; DiPaolo, Donovan and Nelson, 197 (Freeman, Igel and Price, 1975 (Berwald and Sachs, 1965) . The 20% transformation level (T20) then seems to be the critical threshold of transformation for rat cells, above which there is a constant increase. If a line is drawn parallel to the abscissa at the 20% mark on the ordinate (Figs 3 and 4) , it will cut the transformation curves at a point representing a number of passages or days in culture. T20 can therefore serve as a reference point for transformation measurements and, despite the possible variations, it would permit a quantitative evaluation of the transforming effects of the treatments. Since control cells also become transformed, one can also calculate the acceleration of transformation (AT20) caused by a compound, by taking the difference between the T20 of the control cells and the T20 of the treated cells (AT20 =T2C -T20t) expressed in days (Table) .
Malignancy reflects the capacity of transformed cells to form tumours after their inoculation into isologous animals. It is therefore possible to calculate, in days, the acceleration of the acquisition of malignancy (AM) as the difference between the time at which the control cells first exhibit malignancy (Mc) (Table) .
This manner of presenting the results permits us to examine correlations between transformation (T) and malignancy (M) and between the carcinogenic action of the substances in vivo and their action in vitro. During these studies, we noted 50 that in 8 cases, cells showed morphological transformation before they exhibited malignancy, but that in 2 cases (BaPtreated and Cr.Oil-treated) morphological transformation was not seen until after malignancy. Secondly, the BeP + Cr.Oil treatment significantly accelerated cell transformation (110 days) but altered the onset of malignancy to a lesser extent (30 days), whereas Cr.Oil-alone retarded transformation (-60 days) and accelerated malignancy (80 days). These data suggest that even though transformation generally precedes malignancy, the 2 phenomena are not necessarily linked as has been shown with guinea-pig cells (Evans and DiPaolo, 1975) .
When the results (Table) were analysed as a function of the carcinogenic action of the substances used, we noted that the correlation was good for DMBA and BaP alone or combined with TPA or Cr.Oil. The action of TPA alone in vitro is as in vivo. Besides its co-carcinogenic activity, TPA exhibits a weak but definite carcinogenic activity (Chouroulinkov and Lazar, 1974; Hecker, 1966 Hecker, , 1968 .
The acceleration of transformation by BeP + Cr.Oil suggests that BeP is an initiator, which is in accord with the results already observed in vivo (Scribner, 1973) , but these results need to be confirmed in further studies. Cr.Oil treatment gave some disturbing results. The acceleration of malignancy by Cr.Oil can be attributed to its weak tumorigenic activity (Boutwell, Bosch and Rusch, 1957) . The accelerating action on cell malignancy and its retarding effect on transformation are both suppressed when the cells are pretreated with BeP. This observation, and the fact that TPA has no effect on the CE of the cells initiated with DMBA (Table) indicate that the cells pretreated with DMBA or BeP do not respond to Cr.Oil and TPA like normal cells.
If the action of BaP and BeP as initiators is examined, it seems that the 2 hydrocarbons acted on transformation " sites ", since in both cases Cr.Oil accelerated transformation (T). In contrast, the " sites " of the initiation of malignancy were affected by BaP but not by BeP, since Cr.Oil accelerated malignancy in the first case and not in the second. We may conclude that the sites for transformation are different from those involved in malignancy. Other workers have suggested that tumour promoters act in vitro by releasing cells from contact inhibition van Duuren, 1967, 1970 ).
Co-carcinogenesis Berenblum (1974) recently defined the "basic requirements " for the existence of a 2-stage carcinogenesis process, which we have tried to apply to our tissue culture experiments.
1. The 2 separate actions, initiation and promotion, should not overlap in time. Our experiments were designed in such a way that the initiation step, lasting 6 or 24 h, was separated from the first promotion step by 7 days (see Fig. 5 ).
2. Neither action alone should be carcinogenic. As shown, the results do not appear to satisfy this condition, because of the spontaneous transformation of the cells and the positive reactions obtained with both the "initiators" and the " promoters ". However, one should not forget that the cellular model differs from the animal model because of the earlier " spontaneous transformation " of the control cells. (Lasne et al., 1974) , promotion was begun 35 days after initiation, and the results were similar to those presented here.
4. The ultimate tumour yield should be quantitatively related to the dose ofinitiator, while the efficacy and the speed of tumour induction should be determined by the promoter. To respond to this condition, one must see to what extent a qualitative relationship exists between the cutaneous lesions arising during carcinogenesis in vivo and the cellular modifications seen in culture.
On mouse skin, benign tumours develop which may later evolve into malignant tumours, especially if the treatment is continued. However, malignant tumours can also develop directly. Similarly, in cell culture, morphological transformation usually appears before the cells can be shown to be malignant, but the latter can sometimes be demonstrated prior to morphological transformation (Table) .
According to the 4th condition listed as a requirement for 2-stage carcinogenesis, the number of tumours would be determined by the initiation and the latent period for tumour formation by promotion. In culture, initiation actually influences both the amount of cell transformation (expressed as a percentage) and the number of malignant cells, which plays an important role in tumour development. Promotion in vitro affects both the latent period, and the acceleration time.
The results presented here show that the malignant transformation of cells in 2 stages is reproducible in tissue culture, as has been demonstrated in another experimental system using mouse cells (Mondal, Brankow and Heidelberger, 1976) . These authors concluded that the promoters were not acting by selecting transformed cells and that it should be possible to study the mechanisms involved in initiation and promotion in an experimental in vitro system more simply than in the whole animal: cultured cells can be considered as a model system that will facilitate further investigations on the carcinogenic or co-carcinogenic actions of environmental agents.
